|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.90 USD | +0.26% |
|
-1.62% | -4.86% |
| 15/07 | Morgan Stanley Adjusts MetLife Price Target to $98 From $99, Maintains Overweight Rating | MT |
| 11/07 | Autonomous Research Adjusts MetLife's PT to $92 From $88, Keeps Outperform Rating | MT |
| Capitalization | 5.23TCr 4.48TCr 4.17TCr 3.89TCr 7.16TCr 4,49700Cr 7.97TCr 50TCr 19TCr 2,10400Cr 20TCr 19TCr 7,71500Cr | P/E ratio 2025 * |
10.2x | P/E ratio 2026 * | 8.51x |
|---|---|---|---|---|---|
| Enterprise value | 5.23TCr 4.48TCr 4.17TCr 3.89TCr 7.16TCr 4,49700Cr 7.97TCr 50TCr 19TCr 2,10400Cr 20TCr 19TCr 7,71500Cr | EV / Sales 2025 * |
0.69x | EV / Sales 2026 * | 0.67x |
| Free-Float |
47.69% | Yield 2025 * |
2.9% | Yield 2026 * | 3.08% |
More valuation ratios
* Estimated data
More news
Last Transcript: MetLife, Inc.
More recommendations
More press releases
More news
| 1 day | +0.26% | ||
| 1 week | -1.62% | ||
| Current month | -3.13% | ||
| 1 month | +0.71% | ||
| 3 months | +6.79% | ||
| 6 months | -7.07% | ||
| Current year | -4.86% |
| 1 week | 77.21 |  | 80.05 |
| 1 month | 77.21 | | 81.7 |
| Current year | 65.21 | | 88.09 |
| 1 year | 65.21 | | 89.05 |
| 3 years | 48.95 | | 89.05 |
| 5 years | 35.19 | | 89.05 |
| 10 years | 22.85 | | 89.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Khalaf
CEO | Chief Executive Officer | 61 | 01/05/2019 |
John McCallion
DFI | Director of Finance/CFO | 51 | 01/05/2018 |
William Pappas
COO | Chief Operating Officer | 43 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Hubbard
CHM | Chairman | 65 | 01/02/2007 |
Michel Khalaf
BRD | Director/Board Member | 61 | 01/05/2019 |
Carlos Gutierrez
BRD | Director/Board Member | 71 | 08/03/2013 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 1.32% | 21 M€ | +4.65% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.26% | -1.62% | +6.15% | +34.52% | 5.23TCr | ||
| -0.24% | +2.02% | +34.89% | +32.04% | 14TCr | ||
| +0.19% | +0.58% | +29.52% | +101.30% | 11TCr | ||
| +1.08% | -0.20% | +10.83% | +92.09% | 5.55TCr | ||
| 0.00% | +2.02% | +33.21% | +116.87% | 5.54TCr | ||
| +0.07% | -0.26% | +12.81% | +90.51% | 5.2TCr | ||
| -0.42% | +1.51% | +38.32% | +81.26% | 4.7TCr | ||
| -0.41% | -0.88% | -14.41% | +16.66% | 3.74TCr | ||
| -0.38% | +0.77% | +30.25% | +73.79% | 3.54TCr | ||
| +1.15% | +0.23% | +25.44% | +51.91% | 3.54TCr | ||
| Average | +0.13% | +0.27% | +20.70% | +69.09% | 6.12TCr | |
| Weighted average by Cap. | +0.09% | +0.64% | +23.74% | +68.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 7.53TCr 6.45TCr 6TCr 5.6TCr 10TCr 6,47800Cr 11TCr 72TCr 27TCr 3,03100Cr 28TCr 28TCr 11,11400Cr | 7.81TCr 6.69TCr 6.22TCr 5.81TCr 11TCr 6,71700Cr 12TCr 75TCr 28TCr 3,14300Cr 29TCr 29TCr 11,52400Cr |
| Net income | 510.92Cr 437.29Cr 407.16Cr 379.91Cr 699.12Cr 44TCr 779Cr 4.91TCr 1.86TCr 21TCr 1.92TCr 1.88TCr 75TCr | 583.8Cr 499.67Cr 465.23Cr 434.1Cr 798.85Cr 50TCr 890.12Cr 5.61TCr 2.13TCr 23TCr 2.19TCr 2.14TCr 86TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
45,000
Sector
Life & Health Insurance
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/25/14 | 77.90 $ | +0.26% | 21,25,188 |
| 11/25/11 | 77.70 $ | -0.85% | 23,31,899 |
| 10/25/10 | 78.37 $ | +0.17% | 27,88,966 |
| 09/25/09 | 78.24 $ | -1.78% | 26,48,283 |
| 08/25/08 | 79.66 $ | +0.61% | 28,66,025 |
Delayed Quote Nyse, July 15, 2025 at 01:30 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
77.90USD
Average target price
93.57USD
Spread / Average Target
+20.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MET Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition